16:12 EDT Oruka Therapeutics (ORKA) files $1B mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ORKA:
- ORKA-001 Phase 1 Completion: What Oruka’s First-in-Human Milestone Means for Investors
- Oruka Therapeutics price target raised to $86 from $58 at Leerink
- Oruka Therapeutics price target raised to $72 from $47 at Stifel
- Oruka Therapeutics price target raised to $50 from $48 at Barclays
- Oruka Therapeutics reports Q4 EPS (45c), consensus (62c)